omeprazole has been researched along with Esophageal Hernia in 15 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the efficacy of famotidine and omeprazole in Japanese patients with non-erosive gastro-oesophageal reflux disease by a prospective randomized multicentre trial." | 9.11 | Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease. ( Arakawa, T; Chono, S; Fujiwara, Y; Higuchi, K; Kitada, K; Kobayashi, K; Nakagawa, K; Nebiki, H; Oshitani, N; Satoh, H; Tominaga, K; Uno, H; Watanabe, T, 2005) |
| "To compare the efficacy of famotidine and omeprazole in Japanese patients with non-erosive gastro-oesophageal reflux disease by a prospective randomized multicentre trial." | 5.11 | Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease. ( Arakawa, T; Chono, S; Fujiwara, Y; Higuchi, K; Kitada, K; Kobayashi, K; Nakagawa, K; Nebiki, H; Oshitani, N; Satoh, H; Tominaga, K; Uno, H; Watanabe, T, 2005) |
| "Fifty patients with complications or atypical manifestations of gastro-oesophageal reflux disease were given lansoprazole, 30 mg once daily." | 5.10 | Hiatal hernia is the key factor determining the lansoprazole dosage required for effective intra-oesophageal acid suppression. ( De Micheli, E; Frazzoni, M; Grisendi, A; Savarino, V, 2002) |
| "Posttreatment clarithromycin resistance is common in patients who do not experience success with therapy." | 2.68 | Comparison of one or two weeks of lansoprazole, amoxicillin, and clarithromycin in the treatment of Helicobacter pylori. ( Axon, AT; Chalmers, DM; Dixon, MF; Langworthy, H; Moayyedi, P; Shanahan, K; Tompkins, DS, 1996) |
| "Gastroesophageal reflux (GER) occurs in 2 distinct forms that differ in pathophysiology, clinical presentation, natural history, and therapy: mild GER (with no or minimal esophagitis) and classic, severe reflux (at risk for erosive esophagitis)." | 2.40 | Gastroesophageal reflux: practical management of a common, challenging disorder. ( Fass, R; Soll, AH, 1999) |
| "Severe gastroesophageal reflux disease is usually a chronic problem with periods of relapse, but effective medical and surgical therapies are available." | 2.39 | Severe gastroesophageal reflux disease. Medical and surgical options for long-term care. ( Marshall, JB, 1995) |
| "Radical treatment of GERD allows the pulmonologist to perform correct respiratory treatment and to prevent the development chronic and life-threatening complications." | 1.32 | Outcome of laparoscopic Nissen-Rossetti fundoplication in children with gastroesophageal reflux disease and supraesophageal symptoms. ( Castagnetti, M; Gentilino, V; Jasonni, V; Martino, F; Mattioli, G; Montobbio, G; Pini Prato, A; Sacco, O, 2004) |
| "Hypogonadism has been established as a cause of osteoporosis in males, and in this case would explain the occurrence of fractures in the absence of other major risk factors." | 1.31 | Osteoporosis with underlying connective tissue disease: an unusual case. ( De Silva, M; Prasad, R, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (46.67) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sebastián Domingo, JJ | 1 |
| Prasad, R | 1 |
| De Silva, M | 1 |
| Mattioli, G | 1 |
| Sacco, O | 1 |
| Gentilino, V | 1 |
| Martino, F | 1 |
| Pini Prato, A | 1 |
| Castagnetti, M | 1 |
| Montobbio, G | 1 |
| Jasonni, V | 1 |
| Pehl, C | 1 |
| Boccali, I | 1 |
| Hennig, M | 1 |
| Schepp, W | 1 |
| Fujiwara, Y | 1 |
| Higuchi, K | 1 |
| Nebiki, H | 1 |
| Chono, S | 1 |
| Uno, H | 1 |
| Kitada, K | 1 |
| Satoh, H | 1 |
| Nakagawa, K | 1 |
| Kobayashi, K | 1 |
| Tominaga, K | 1 |
| Watanabe, T | 1 |
| Oshitani, N | 1 |
| Arakawa, T | 1 |
| Hata, M | 1 |
| Shiono, M | 1 |
| Sekino, H | 1 |
| Furukawa, H | 1 |
| Sezai, A | 1 |
| Iida, M | 1 |
| Yoshitake, I | 1 |
| Hattori, T | 1 |
| Wakui, S | 1 |
| Taoka, M | 1 |
| Negishi, N | 1 |
| Sezai, Y | 1 |
| Marshall, JB | 1 |
| Polonio García, MJ | 1 |
| Merino Romero, J | 1 |
| Luque Ruano, A | 1 |
| Sánchez Sánchez, JE | 1 |
| Tibbling, L | 1 |
| McKenzie, D | 1 |
| Grayson, T | 1 |
| Polk, HC | 1 |
| Moayyedi, P | 1 |
| Langworthy, H | 1 |
| Shanahan, K | 1 |
| Tompkins, DS | 1 |
| Dixon, MF | 1 |
| Chalmers, DM | 1 |
| Axon, AT | 1 |
| de Mestier, P | 1 |
| Soll, AH | 1 |
| Fass, R | 1 |
| Grahn, LT | 1 |
| Frazzoni, M | 1 |
| De Micheli, E | 1 |
| Grisendi, A | 1 |
| Savarino, V | 1 |
4 reviews available for omeprazole and Esophageal Hernia
| Article | Year |
|---|---|
Severe gastroesophageal reflux disease. Medical and surgical options for long-term care.
Topics: Antacids; Anti-Ulcer Agents; Cisapride; Drug Therapy, Combination; Esophageal Diseases; Esophagogast | 1995 |
[Omeprazole treatment and fever].
Topics: Aged; Aged, 80 and over; Fever; Gastritis; Hernia, Hiatal; Humans; Male; Omeprazole | 1994 |
The impact of omeprazole and laparoscopy upon hiatal hernia and reflux esophagitis.
Topics: Anti-Ulcer Agents; Esophagitis, Peptic; Fundoplication; Hernia, Hiatal; Humans; Laparoscopy; Omepraz | 1996 |
Gastroesophageal reflux: practical management of a common, challenging disorder.
Topics: Anti-Ulcer Agents; Barrett Esophagus; Cisapride; Endoscopy, Gastrointestinal; Gastrins; Gastroesopha | 1999 |
3 trials available for omeprazole and Esophageal Hernia
| Article | Year |
|---|---|
Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
Topics: Anti-Ulcer Agents; Famotidine; Female; Gastroesophageal Reflux; Helicobacter Infections; Helicobacte | 2005 |
Comparison of one or two weeks of lansoprazole, amoxicillin, and clarithromycin in the treatment of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alcohol Drinking; Amoxicillin; Clarithromycin; Drug Therapy | 1996 |
Hiatal hernia is the key factor determining the lansoprazole dosage required for effective intra-oesophageal acid suppression.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Gastro | 2002 |
8 other studies available for omeprazole and Esophageal Hernia
| Article | Year |
|---|---|
Omeprazole-induced hallucinations. Not as rare as you might think.
Topics: Adult; Drug Substitution; Esomeprazole; Esophagitis, Peptic; Hallucinations; Hernia, Hiatal; Humans; | 2018 |
Osteoporosis with underlying connective tissue disease: an unusual case.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Accidental Falls; Adult; Anti-Ulcer Agents; Antibodies, Ant | 2002 |
Outcome of laparoscopic Nissen-Rossetti fundoplication in children with gastroesophageal reflux disease and supraesophageal symptoms.
Topics: Adolescent; Anti-Ulcer Agents; Asthma; Child; Child, Preschool; Combined Modality Therapy; Domperido | 2004 |
pH probe positioning for 24-hour pH-metry by manometry or pH step-up.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Benzimidazoles; Enzyme Inhibitors; Female; Gas | 2004 |
Efficacy of a proton pump inhibitor given in the early postoperative period to relieve symptoms of hiatal hernia after open heart surgery.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Benzimidazoles; Cardiac Sur | 2006 |
Wrong-way swallowing as a possible cause of bronchitis in patients with gastroesophageal reflux disease.
Topics: Bronchitis; Chronic Disease; Cough; Deglutition Disorders; Female; Gastroesophageal Reflux; Hernia, | 1993 |
[Congress of the American College of Surgeons (ACS). San Francisco, 10-15 October 1999].
Topics: Anti-Ulcer Agents; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholang | 1999 |
Longitudinal oesophageal muscle and pharyngo-oesophageal dysphagia--a deductive study.
Topics: Anti-Ulcer Agents; Bronchitis; Deglutition Disorders; Esophagogastric Junction; Esophagus; Gastroeso | 2000 |